Plasma TK1 has previously been shown to be a prognostic marker for survival as it is a reflection of the tumour burden [26,27,28] and was similarly demonstrated in our study independently of its effect on 18F-FLT uptake. This evidence concerns the gene TK1 and neoplasm.